UBS Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

UBS Group’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-156	Closed	-$51K	–	8300
2015 Q4	$51K	Hold	156	–	–	﹤0.01%	5798
2015 Q3	$50K	Hold	156	–	–	﹤0.01%	5837
2015 Q2	$62K	Sell	156 -277	-64%	-$118K	﹤0.01%	5817
2015 Q1	$213K	Sell	433 -245	-36%	-$94.9K	﹤0.01%	4830
2014 Q4	$242K	Buy	+678	New	+$202K	﹤0.01%	4858

UBS Group's LUMO Position: Q4 2024 in Review

UBS Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 6,557 shares — an estimated $25.4K sold.

UBS Group first reported a position in LUMO in Q4 2014 and held it in 36 quarters. The position peaked at $2.76M in Q4 2015. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.

UBS Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
UBS Group sold 6,557 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $25.4K.
UBS Group first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2014 and held it in 36 quarters.
UBS Group's Lumos Pharma, Inc. Common Stock position peaked at $2.76M in Q4 2015.
0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.